Valuation: Futura Medical plc

Market Cap 2.33M 3.11M 2.72M 2.51M 4.41M 295M 4.49M 30.08M 11.7M 146M 11.68M 11.43M 504M P/E 2024
77.2x
P/E 2025 -0.4x
Enterprise Value -1.08M -1.44M -1.26M -1.16M -2.04M -137M -2.08M -13.92M -5.41M -67.44M -5.41M -5.29M -233M EV / Sales 2024
6,428,637x
EV / Sales 2025 1,815,433x
Free-Float
83.88%
Yield 2024 *
-
Yield 2025 -
1 day+1.25%
1 week-22.12%
Current month-22.12%
1 month-32.50%
3 months-61.24%
6 months-67.47%
Current year-63.68%
1 week 0.35
Extreme 0.3501
0.57
1 month 0.35
Extreme 0.3501
0.73
Current year 0.35
Extreme 0.3501
1.75
1 year 0.35
Extreme 0.3501
15
3 years 0.35
Extreme 0.3501
61.5
5 years 0.35
Extreme 0.3501
67
10 years 0.35
Extreme 0.3501
95.6
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-07
Director of Finance/CFO 46 2018-02-19
Chief Tech/Sci/R&D Officer 74 2016-11-15
Director TitleAgeSince
Director/Board Member 74 2016-03-31
Director/Board Member 46 2018-02-19
Chairman 69 -
Date Insider Type Main position Quantity % Market Cap.
12-07Buy

Chief Financial Officer

500,000 0.1488%
12-07Buy

Chief Executive Officer

5,000,000 1.4876%
12-07Buy

Chief Technology Officer

500,000 0.1488%
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-22.12%-94.74%-99.26% 3.11M
-0.94%+1.36%+73.32%+128.78% 57.72B
-3.80%-6.24%+67.04%+86.36% 52.65B
+1.17%+5.83%+16.39%+468.18% 24.46B
+0.38%+1.33%-14.32%-11.76% 23.84B
-3.05%+3.06%+42.36%-5.66% 19.28B
-0.73%+4.71%+43.69%-26.90% 17.8B
+3.46%+17.72%+206.66%+364.07% 17.29B
-6.73%+9.90%+36.04% - 15.28B
+2.79%+4.91%+29.26%+195.60% 14.35B
Average -0.62%+2.33%+40.57%+122.16% 24.27B
Weighted average by Cap. -1.21%+2.58%+57.52%+139.24%

Financials

2024 2025
Net sales 13.93 18.63 16.3 15.02 26.44 1.77K 26.86 180.16 70.06 872.61 69.94 68.43 3.02K 1.7 2.27 1.99 1.83 3.22 215.42 3.27 21.95 8.54 106.31 8.52 8.34 367.46
Net income 1.29M 1.73M 1.51M 1.4M 2.45M 164M 2.49M 16.73M 6.51M 81.02M 6.49M 6.35M 280M -9.07M -12.13M -10.62M -9.79M -17.22M -1.15B -17.5M -117M -45.63M -568M -45.56M -44.57M -1.96B
Net Debt -6.6M -8.82M -7.72M -7.12M -12.52M -837M -12.72M -85.33M -33.18M -413M -33.13M -32.41M -1.43B -3.4M -4.55M -3.98M -3.67M -6.46M -432M -6.56M -44.01M -17.11M -213M -17.08M -16.71M -737M
Logo Futura Medical plc
Futura Medical plc is a consumer healthcare company that specializes in the development and global commercialization of sexual health products. The Company is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The Company has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.
Employees
13
Date Price Change Volume
26-07-08 GBX 0.4050 +1.25% 4,929,774
26-07-07 GBX 0.4000 -27.80% 7,041,893
26-07-06 GBX 0.5540 -0.72% 8,203,238
26-07-03 GBX 0.5580 +9.41% 9,313,111
26-07-02 GBX 0.5100 +10.87% 5,393,220

Annual profits - Rate of surprise